X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5125) 5125
Book Review (810) 810
Publication (407) 407
Book Chapter (13) 13
Magazine Article (9) 9
Book / eBook (7) 7
Conference Proceeding (7) 7
Dissertation (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4909) 4909
index medicus (4793) 4793
male (3397) 3397
female (3219) 3219
middle aged (3107) 3107
aged (2593) 2593
adult (2157) 2157
oncology (2002) 2002
oropharyngeal cancer (1697) 1697
head (1613) 1613
cancer (1602) 1602
radiotherapy (1529) 1529
squamous-cell carcinoma (1418) 1418
surgery (1407) 1407
oropharyngeal neoplasms - pathology (1399) 1399
otorhinolaryngology (1317) 1317
squamous cell carcinoma (1250) 1250
neck-cancer (1249) 1249
carcinoma, squamous cell - pathology (1235) 1235
aged, 80 and over (1174) 1174
retrospective studies (1135) 1135
oropharyngeal neoplasms - radiotherapy (1115) 1115
prognosis (1114) 1114
neoplasm staging (1088) 1088
head and neck cancer (1040) 1040
treatment outcome (978) 978
oropharyngeal neoplasms - surgery (911) 911
carcinoma, squamous cell - radiotherapy (849) 849
oropharyngeal neoplasms - therapy (842) 842
survival (832) 832
chemotherapy (815) 815
care and treatment (808) 808
carcinoma, squamous cell - surgery (771) 771
human-papillomavirus (768) 768
human papillomavirus (735) 735
carcinoma, squamous cell - mortality (731) 731
carcinoma, squamous cell - therapy (727) 727
combined modality therapy (711) 711
radiation-therapy (698) 698
radiology, nuclear medicine & medical imaging (690) 690
papillomavirus infections (688) 688
oropharyngeal neoplasms - mortality (672) 672
follow-up studies (663) 663
analysis (647) 647
carcinoma, squamous cell - virology (623) 623
hematology, oncology and palliative medicine (620) 620
neck (618) 618
oropharyngeal neoplasms - virology (617) 617
dentistry, oral surgery & medicine (574) 574
risk factors (560) 560
survival rate (553) 553
radiotherapy dosage (549) 549
disease-free survival (543) 543
head and neck neoplasms - pathology (541) 541
head and neck neoplasms - radiotherapy (517) 517
prospective studies (471) 471
survival analysis (470) 470
research (460) 460
abridged index medicus (455) 455
chemoradiotherapy (440) 440
quality-of-life (437) 437
oropharyngeal neoplasms - drug therapy (436) 436
radiation (436) 436
tumors (427) 427
oropharyngeal carcinoma (425) 425
carcinoma (422) 422
hpv (420) 420
head and neck neoplasms - therapy (417) 417
mouth neoplasms - pathology (410) 410
dentistry (409) 409
squamous cell carcinoma of head and neck (404) 404
papillomavirus infections - complications (395) 395
patients (395) 395
oropharynx (388) 388
quality of life (385) 385
mouth neoplasms - surgery (380) 380
carcinoma, squamous cell - drug therapy (379) 379
radiation therapy (374) 374
otolaryngology (357) 357
throat cancer (356) 356
medicine & public health (347) 347
lymphatic metastasis (344) 344
health aspects (343) 343
immunohistochemistry (338) 338
head and neck neoplasms - mortality (329) 329
head and neck neoplasms - virology (320) 320
locally advanced head (318) 318
therapy (317) 317
papillomavirus infections - virology (314) 314
oropharyngeal neoplasms - diagnosis (309) 309
article (305) 305
time factors (297) 297
antineoplastic combined chemotherapy protocols - therapeutic use (294) 294
mouth neoplasms - radiotherapy (287) 287
head & neck cancer (284) 284
neck dissection (283) 283
metastasis (280) 280
kaplan-meier estimate (277) 277
cohort studies (276) 276
radiology (271) 271
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4707) 4707
German (189) 189
French (86) 86
Russian (50) 50
Japanese (43) 43
Spanish (24) 24
Italian (16) 16
Polish (16) 16
Chinese (3) 3
Croatian (3) 3
Dutch (3) 3
Hungarian (2) 2
Portuguese (2) 2
Czech (1) 1
Danish (1) 1
Hebrew (1) 1
Korean (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oral Oncology, ISSN 1368-8375, 2012, Volume 49, Issue 1, pp. 79 - 85
Summary Objectives To describe the natural course of distant metastases (DMs) following radiotherapy (RT) or chemoradiotherapy (CRT) in HPV(+) oropharyngeal... 
Otolaryngology | Hematology, Oncology and Palliative Medicine | Distant metastasis | Human papillomavirus | Oropharyngeal carcinoma | Radiotherapy | Chemoradiotherapy | SURVIVAL | HEAD | HUMAN-PAPILLOMAVIRUS | P16(INK4A) | SUBSET | PHASE-III TRIAL | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | DENTISTRY, ORAL SURGERY & MEDICINE | SQUAMOUS-CELL CARCINOMA | EPSTEIN-BARR-VIRUS | NECK-CARCINOMA | Oropharyngeal Neoplasms - therapy | Papillomavirus Infections - radiotherapy | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Carcinoma - virology | Salvage Therapy | Male | Papillomavirus Infections - therapy | Neoplasm Recurrence, Local - pathology | Lung Neoplasms - secondary | Tongue Neoplasms - virology | Aged, 80 and over | Adult | Female | Retrospective Studies | Tonsillar Neoplasms - therapy | Liver Neoplasms - secondary | Carcinoma - secondary | Tongue Neoplasms - radiotherapy | Liver Neoplasms - virology | Radiotherapy Dosage | Tongue Neoplasms - therapy | Alphapapillomavirus - classification | Oropharyngeal Neoplasms - radiotherapy | Survival Rate | Oropharyngeal Neoplasms - virology | Carcinoma - radiotherapy | Lung Neoplasms - virology | Tonsillar Neoplasms - radiotherapy | Tonsillar Neoplasms - virology | Skin Neoplasms - virology | Skin Neoplasms - secondary | Carcinoma - therapy | Aged | Neoplasm Staging | Cohort Studies | Care and treatment | Metastasis | Nuclear radiation | Papillomavirus infections | Cancer | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 67, pp. 174 - 182
Abstract Aim The aim is to evaluate the impact of cisplatin dose modification on outcomes of human papillomavirus (HPV)-related (HPV+) and HPV-unrelated (HPV−)... 
Hematology, Oncology and Palliative Medicine | Head and neck cancer | Human papillomavirus | Survival | Chemoradiotherapy | Cisplatin | THERAPY | ONCOLOGY | OROPHARYNGEAL CANCER | RADIOTHERAPY | EXPRESSION | Oropharyngeal Neoplasms - therapy | Head and Neck Neoplasms - virology | Hypopharyngeal Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Case-Control Studies | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Aged, 80 and over | Adult | Female | Retrospective Studies | Papillomavirus Infections - complications | Head and Neck Neoplasms - therapy | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Oropharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - complications | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Carcinoma, Squamous Cell - complications | Hypopharyngeal Neoplasms - pathology | Radiotherapy, Conformal | Head and Neck Neoplasms - complications | Aged | Hypopharyngeal Neoplasms - complications | Neoplasm Staging | Laryngeal Neoplasms - complications | Laryngeal Neoplasms - virology | Radiotherapy, Intensity-Modulated | Papillomaviruses | Antimitotic agents | Squamous cell carcinoma | Antineoplastic agents | Papillomavirus infections | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2017, Volume 98, Issue 4, pp. 784 - 792
Purpose To determine the patterns of adjuvant chemoradiotherapy use in elderly patients treated with definitive surgical resection for squamous cell carcinoma... 
Radiology | Hematology, Oncology and Palliative Medicine | UNITED-STATES | TRIALS | THERAPY | ONCOLOGY | LOCALLY ADVANCED HEAD | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | Oropharyngeal Neoplasms - therapy | Hypopharyngeal Neoplasms - surgery | Radiotherapy, Intensity-Modulated - statistics & numerical data | United States | Carcinoma, Squamous Cell - pathology | Humans | Oropharyngeal Neoplasms - mortality | Carcinoma, Squamous Cell - surgery | Male | Oropharyngeal Neoplasms - pathology | Practice Patterns, Physicians | Hypopharyngeal Neoplasms - mortality | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Chemoradiotherapy, Adjuvant - statistics & numerical data | Female | Laryngeal Neoplasms - surgery | Databases, Factual - statistics & numerical data | Head and Neck Neoplasms - therapy | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Mouth Neoplasms - mortality | Mouth Neoplasms - therapy | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Oropharyngeal Neoplasms - surgery | Propensity Score | Laryngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - pathology | Mouth Neoplasms - surgery | Mouth Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Head and Neck Neoplasms - surgery | Aged patients | Squamous cell carcinoma | Databases | Surgery | Risk factors | Medical research | Chemotherapy | Radiation | Medicine, Experimental | Radiotherapy | Cancer | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 91, Issue 4, pp. 721 - 729
Purpose To evaluate candidate fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging biomarkers for head-and-neck... 
Radiology | Hematology, Oncology and Palliative Medicine | FDG-PET/CT | PREDICTS | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | HUMAN-PAPILLOMAVIRUS | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ACCURACY | Fluorodeoxyglucose F18 - pharmacokinetics | Confidence Intervals | Prognosis | Follow-Up Studies | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Laryngeal Neoplasms - diagnostic imaging | Male | Oropharyngeal Neoplasms - pathology | Positron-Emission Tomography - instrumentation | Head and Neck Neoplasms - metabolism | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Adult | Female | Tomography, X-Ray Computed - instrumentation | Chemoradiotherapy - methods | Radiopharmaceuticals - pharmacokinetics | Blood Glucose - analysis | Head and Neck Neoplasms - diagnostic imaging | Laryngeal Neoplasms - metabolism | Head and Neck Neoplasms - therapy | Lymphatic Metastasis | Positron-Emission Tomography - methods | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Disease-Free Survival | Phenotype | Hypopharyngeal Neoplasms - metabolism | Hypopharyngeal Neoplasms - pathology | Aged | Neoplasm Staging | Hypopharyngeal Neoplasms - diagnostic imaging | Sects | Radiotherapy | Radiation | Cancer | Index Medicus | HEAD | PATIENTS | NEOPLASMS | BIOMEDICAL RADIOGRAPHY | BIOLOGICAL MARKERS | POSITRON COMPUTED TOMOGRAPHY | FLUORODEOXYGLUCOSE | UPTAKE | RADIOLOGY AND NUCLEAR MEDICINE | NECK | COMBINED THERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 1823 - 1830
Purpose The tumor volume has been established as a significant predictor of outcomes among patients with head-and-neck cancer undergoing radiotherapy alone.... 
Radiology | Hematology, Oncology and Palliative Medicine | Primary tumor volume | Head and neck cancer | TNM staging | Tumor recurrence | Chemoradiotherapy | Survival | STAGE | POSITIVE HEAD | LARYNX | COMPUTED-TOMOGRAPHY | HYPOPHARYNGEAL CANCER | ONCOLOGY | RADIOTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CONCURRENT CHEMORADIOTHERAPY | Oropharyngeal Neoplasms - therapy | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Oropharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - mortality | Laryngeal Neoplasms - diagnostic imaging | Male | Carcinoma, Squamous Cell - diagnostic imaging | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Chemoradiotherapy - methods | Head and Neck Neoplasms - diagnostic imaging | Head and Neck Neoplasms - therapy | Neoplasm Recurrence, Local | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Tumor Burden | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Radiography | Disease-Free Survival | Analysis of Variance | Laryngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Neoplasm Staging | Hypopharyngeal Neoplasms - diagnostic imaging | Medical colleges | Care and treatment | Nuclear radiation | Patient outcomes | Oncology, Experimental | Research | Radiotherapy | Tumors | Cancer | Index Medicus | HEAD | PATIENTS | NEOPLASMS | FAILURES | METASTASES | COMPUTERIZED TOMOGRAPHY | PLANNING | MULTIVARIATE ANALYSIS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | COMBINED THERAPY | HAZARDS
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 12, pp. 1300 - 1308
Purpose We conducted a retrospective evaluation of the IMCL-9815 study to examine the association of human papillomavirus (HPV) and p16 protein expression... 
SURVIVAL | PANITUMUMAB | THERAPY | ONCOLOGY | RECURRENT | CHEMORADIOTHERAPY | RISK | CANCER | CHEMOTHERAPY | Immunohistochemistry | Oropharyngeal Neoplasms - therapy | Predictive Value of Tests | Chemoradiotherapy - adverse effects | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Male | Antineoplastic Agents - therapeutic use | Oropharyngeal Neoplasms - pathology | Cetuximab - therapeutic use | Papillomaviridae - genetics | Cetuximab - adverse effects | Clinical Trials, Phase III as Topic | Head and Neck Neoplasms - chemistry | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Time Factors | Antineoplastic Agents - adverse effects | Female | Retrospective Studies | Biomarkers, Tumor - analysis | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Carcinoma, Squamous Cell - chemistry | Treatment Outcome | Oropharyngeal Neoplasms - virology | Papillomaviridae - isolation & purification | Head and Neck Neoplasms - pathology | Randomized Controlled Trials as Topic | Disease-Free Survival | Oropharyngeal Neoplasms - chemistry | Aged | Human Papillomavirus DNA Tests | Head and Neck Neoplasms - mortality | DNA, Viral - genetics | Index Medicus | Hnc16 | ORIGINAL REPORTS | Hnc6
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 5, pp. 543 - 550
Journal Article
Head & Neck, ISSN 1043-3074, 11/2015, Volume 37, Issue 11, pp. 1603 - 1611
Background. Amidst a rising incidence of p16-positive (p16+) oropharyngeal cancer, a significant number of cases present as regionally metastatic disease with... 
transoral laser microsurgery (TLM) | transoral robotic surgery (TORS) | human papillomavirus (HPV) | unknown primary | p16 | Transoral robotic surgery (TORS) | Human papillomavirus (HPV) | Unknown primary | P16 | Transoral laser microsurgery (TLM) | SURGERY | PRIMARY TUMORS | DIAGNOSIS | ROBOTIC SURGERY | PRIMARY ORIGIN | CANCER | CHEMOTHERAPY | LYMPH-NODE METASTASES | OTORHINOLARYNGOLOGY | SQUAMOUS-CELL CARCINOMA | LOCALLY ADVANCED HEAD | OCCULT HEAD | Oropharyngeal Neoplasms - therapy | Head and Neck Neoplasms - secondary | Head and Neck Neoplasms - virology | Follow-Up Studies | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Tumor Virus Infections - diagnosis | Male | Oropharyngeal Neoplasms - pathology | Papillomavirus Infections - diagnosis | Papillomavirus Infections - therapy | Tongue Neoplasms - virology | Tumor Virus Infections - therapy | Adult | Female | Databases, Factual | Tongue Neoplasms - mortality | Neoplasms, Unknown Primary - surgery | Chemoradiotherapy - methods | Risk Assessment | Tongue Neoplasms - therapy | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Treatment Outcome | Tumor Virus Infections - mortality | Combined Modality Therapy | Oropharyngeal Neoplasms - virology | Neoplasms, Unknown Primary - mortality | Papillomaviridae - isolation & purification | Tongue Neoplasms - pathology | Disease-Free Survival | Natural Orifice Endoscopic Surgery - methods | Survival Analysis | Aged | Head and Neck Neoplasms - mortality | Microsurgery - methods | Cohort Studies | Neoplasms, Unknown Primary - pathology | Papillomaviruses | Papillomavirus infections | Index Medicus
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 09/2017, Volume 117, Issue 6, pp. 876 - 883
Background: Following chemo-radiotherapy (CCRT) for human papilloma virus positive (HPV+) locally advanced head and neck cancer, patients frequently undergo... 
METAANALYSIS | head and neck cancer | plasma HPV DNA | HUMAN-PAPILLOMAVIRUS DNA | CANCER | CELL CARCINOMA | response prediction | POLYMERASE-CHAIN-REACTION | PLASMA | CISPLATIN | ONCOLOGY | DISSECTION | CHEMORADIATION | SURVEILLANCE | Laryngeal Neoplasms - blood | Oropharyngeal Neoplasms - therapy | Carcinoma, Squamous Cell - blood | Hypopharyngeal Neoplasms - surgery | Prospective Studies | Carcinoma, Squamous Cell - pathology | Humans | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Treatment Outcome | Oropharyngeal Neoplasms - pathology | Chemoradiotherapy | Hypopharyngeal Neoplasms - blood | Head and Neck Neoplasms - pathology | Laryngeal Neoplasms - pathology | DNA, Viral - blood | Neoplasm, Residual | Laryngeal Neoplasms - therapy | Head and Neck Neoplasms - blood | Hypopharyngeal Neoplasms - pathology | Sensitivity and Specificity | Oropharyngeal Neoplasms - blood | Human papillomavirus 16 - genetics | Neck Dissection | Head | Identification methods | Liver | Medical services | Positron emission | Viruses | Radiation therapy | Patients | Morbidity | Gene sequencing | Polymerase chain reaction | Sensitivity | Human papillomavirus | Biopsy | Tomography | Head and neck cancer | Neck | Dissection | Deoxyribonucleic acid--DNA | DNA sequencing | Cancer | Tumors | Index Medicus | Genetics & Genomics
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 11, pp. 2522 - 2530
Abstract Patients with human papillomavirus (HPV) positive tonsillar and base of tongue squamous cell carcinoma (TSCC and BOTSCC, respectively) have a better... 
Hematology, Oncology and Palliative Medicine | CD8+ TILs | Clinical outcome | Base of tongue cancer | CD4+ TILs | Tonsillar cancer | HPV | CD4 | CD8 | TILs | HEAD | PROGNOSIS | VACCINE | RISK | CERVICAL-CANCER | NECK-CANCER | ONCOLOGY | CD4(+) TILs | OROPHARYNGEAL CANCER | CD8(+) TILs | EPIDEMIC | EXPRESSION | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Tonsillar Neoplasms - immunology | CD4-Positive T-Lymphocytes - immunology | Papillomaviridae - immunology | Squamous Cell Carcinoma of Head and Neck | Tongue Neoplasms - virology | Aged, 80 and over | Papillomavirus Infections - immunology | Adult | Female | Papillomavirus Infections - virology | Tonsillar Neoplasms - therapy | Tonsillar Neoplasms - pathology | Tongue Neoplasms - therapy | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Treatment Outcome | Papillomaviridae - isolation & purification | Carcinoma, Squamous Cell - immunology | Tongue Neoplasms - pathology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - immunology | Pilot Projects | Tonsillar Neoplasms - virology | Aged | Tongue Neoplasms - immunology | CD8-Positive T-Lymphocytes - immunology | Biomarkers, Tumor - immunology | Lymphocytes, Tumor-Infiltrating - immunology | CD4 antigen | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 91, Issue 5, pp. 916 - 924
Purpose To report the long-term results of the ARO 95-06 randomized trial comparing hyperfractionated accelerated chemoradiation with mitomycin... 
Radiology | Hematology, Oncology and Palliative Medicine | Oropharyngeal Neoplasms - therapy | Confidence Intervals | Follow-Up Studies | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Male | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Carcinoma, Squamous Cell - radiotherapy | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Adult | Dose Fractionation | Female | Chemoradiotherapy - methods | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Survival Rate | Mouth Neoplasms - mortality | Mouth Neoplasms - therapy | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Head and Neck Neoplasms - radiotherapy | Regression Analysis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hypopharyngeal Neoplasms - pathology | Mouth Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Mitomycin - administration & dosage | Population Surveillance | Clinical trials | Sects | Head and neck cancer | Hospitals | Radiotherapy | Radiation | Index Medicus | RANDOMNESS | HEAD | PATIENTS | ORAL CAVITY | URACILS | NEOPLASMS | MITOMYCIN | RADIATION DOSES | COMPARATIVE EVALUATIONS | MULTIVARIATE ANALYSIS | RADIOLOGY AND NUCLEAR MEDICINE | REGRESSION ANALYSIS | NECK | RADIOTHERAPY | HAZARDS
Journal Article
Head & Neck, ISSN 1043-3074, 12/2012, Volume 34, Issue 12, pp. 1681 - 1703
Journal Article